tiprankstipranks
Advertisement
Advertisement

DE:TKDA Stock Latest News

Takeda announces publication of data from Phase 3 studies of oveporexton
The FlyTakeda announces publication of data from Phase 3 studies of oveporexton
3d ago
TAK
Protagonist Therapeutics announces $300M share repurchase program
PremiumThe Fly
Protagonist Therapeutics announces $300M share repurchase program
3d ago
JNJ
TAK
Keros Therapeutics announces $5M share repurchase program after Takeda payment
PremiumThe Fly
Keros Therapeutics announces $5M share repurchase program after Takeda payment
3d ago
TAK
KROS
Trump Trade: President warns communities against rejecting data centers
PremiumThe Fly
Trump Trade: President warns communities against rejecting data centers
11d ago
AZN
LLY
Protagonist Therapeutics price target raised to $190 from $178 at BMO Capital
PremiumThe Fly
Protagonist Therapeutics price target raised to $190 from $178 at BMO Capital
11d ago
TAK
PTGX
Bayer, Takeda expected to announce new pricing deals with White House, FT says
PremiumThe FlyBayer, Takeda expected to announce new pricing deals with White House, FT says
11d ago
AZN
LLY
Protagonist Therapeutics price target raised to $170 from $167 at H.C. Wainwright
Premium
The Fly
Protagonist Therapeutics price target raised to $170 from $167 at H.C. Wainwright
12d ago
TAK
PTGX
Protagonist announces Takeda received U.S. FDA approval for MIMRYLO
Premium
The Fly
Protagonist announces Takeda received U.S. FDA approval for MIMRYLO
12d ago
TAK
PTGX
Takeda receives FDA approval of NDA for Mimrylo
PremiumThe Fly
Takeda receives FDA approval of NDA for Mimrylo
14d ago
TAK
Novavax’s partners approved for Nuvaxovid formulation for vaccination season
PremiumThe Fly
Novavax’s partners approved for Nuvaxovid formulation for vaccination season
15d ago
SNY
TAK
Takeda announces Japan MHLW approval for Orzeyful
PremiumThe Fly
Takeda announces Japan MHLW approval for Orzeyful
19d ago
TAK
Analyst Raises Price Target to ¥6,800 and Reiterates Buy on Strong Drug Performance, Pipeline Upside, and Long-Term Growth Drivers
PremiumRatings
Analyst Raises Price Target to ¥6,800 and Reiterates Buy on Strong Drug Performance, Pipeline Upside, and Long-Term Growth Drivers
30d ago
TAK
Takeda award from Veterans Affairs posted to SAM.gov site
PremiumThe FlyTakeda award from Veterans Affairs posted to SAM.gov site
1M ago
TAK
FDA approves Takeda’s Orzeyful to treat narcolepsy type 1
Premium
The Fly
FDA approves Takeda’s Orzeyful to treat narcolepsy type 1
1M ago
TAK
FDA approves Takeda’s Orzeyful to treat narcolepsy type 1 in adults
Premium
The Fly
FDA approves Takeda’s Orzeyful to treat narcolepsy type 1 in adults
1M ago
TAK
Takeda Earnings Call: FX Tailwinds, Pipeline Firepower
PremiumCompany Announcements
Takeda Earnings Call: FX Tailwinds, Pipeline Firepower
1M ago
TAK
Keros Therapeutics to receive $20M elritercept milestone payment from Takeda
PremiumThe Fly
Keros Therapeutics to receive $20M elritercept milestone payment from Takeda
1M ago
TAK
KROS
Mamegano Reiterates Buy on Takeda as Q1 Beat and Pipeline Progress Support Unchanged Price Objective
PremiumRatings
Mamegano Reiterates Buy on Takeda as Q1 Beat and Pipeline Progress Support Unchanged Price Objective
1M ago
TAK
Takeda dengue vaccine receives marketing authorization from India DCGI
PremiumThe Fly
Takeda dengue vaccine receives marketing authorization from India DCGI
2M ago
TAK
Takeda, the Indoensian Government announce collaboration
PremiumThe FlyTakeda, the Indoensian Government announce collaboration
2M ago
TAK
Takeda Files July 2026 Corporate Governance Report Highlighting Full Code Compliance
Premium
Company Announcements
Takeda Files July 2026 Corporate Governance Report Highlighting Full Code Compliance
2M ago
6K
TAK
Takeda Updates Articles of Incorporation in June 2026 SEC Filing
Premium
Company Announcements
Takeda Updates Articles of Incorporation in June 2026 SEC Filing
2M ago
6K
TAK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >